BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37459649)

  • 21. TRPC1 is a differential regulator of hypoxia-mediated events and Akt signalling in PTEN-deficient breast cancer cells.
    Azimi I; Milevskiy MJG; Kaemmerer E; Turner D; Yapa KTDS; Brown MA; Thompson EW; Roberts-Thomson SJ; Monteith GR
    J Cell Sci; 2017 Jul; 130(14):2292-2305. PubMed ID: 28559303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intermittent hypoxia increases kidney tumor vascularization in a murine model of sleep apnea.
    Vilaseca A; Campillo N; Torres M; Musquera M; Gozal D; Montserrat JM; Alcaraz A; Touijer KA; Farré R; Almendros I
    PLoS One; 2017; 12(6):e0179444. PubMed ID: 28594929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypoxia-regulated overexpression of soluble VEGFR2 controls angiogenesis and inhibits tumor growth.
    Collet G; Lamerant-Fayel N; Tertil M; El Hafny-Rahbi B; Stepniewski J; Guichard A; Foucault-Collet A; Klimkiewicz K; Petoud S; Matejuk A; Grillon C; Jozkowicz A; Dulak J; Kieda C
    Mol Cancer Ther; 2014 Jan; 13(1):165-78. PubMed ID: 24170768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spheroid culture models adequately imitate distinctive features of the renal cancer or melanoma microenvironment.
    Filipiak-Duliban A; Brodaczewska K; Majewska A; Kieda C
    In Vitro Cell Dev Biol Anim; 2022 May; 58(5):349-364. PubMed ID: 35536385
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GDC-0941 inhibits metastatic characteristics of thyroid carcinomas by targeting both the phosphoinositide-3 kinase (PI3K) and hypoxia-inducible factor-1α (HIF-1α) pathways.
    Burrows N; Babur M; Resch J; Ridsdale S; Mejin M; Rowling EJ; Brabant G; Williams KJ
    J Clin Endocrinol Metab; 2011 Dec; 96(12):E1934-43. PubMed ID: 21994956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apoptosis regulator through modulating IAP expression (ARIA) controls the PI3K/Akt pathway in endothelial and endothelial progenitor cells.
    Koide M; Ikeda K; Akakabe Y; Kitamura Y; Ueyama T; Matoba S; Yamada H; Okigaki M; Matsubara H
    Proc Natl Acad Sci U S A; 2011 Jun; 108(23):9472-7. PubMed ID: 21593423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms underlying PTEN regulation of vascular endothelial growth factor and angiogenesis.
    Gomez-Manzano C; Fueyo J; Jiang H; Glass TL; Lee HY; Hu M; Liu JL; Jasti SL; Liu TJ; Conrad CA; Yung WK
    Ann Neurol; 2003 Jan; 53(1):109-17. PubMed ID: 12509854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of Mel-18 induces tumor angiogenesis through enhancing the activity and expression of HIF-1α mediated by the PTEN/PI3K/Akt pathway.
    Park JH; Lee JY; Shin DH; Jang KS; Kim HJ; Kong G
    Oncogene; 2011 Nov; 30(45):4578-89. PubMed ID: 21602890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PI3 kinase blockade by Ad-PTEN inhibits invasion and induces apoptosis in RGP and metastatic melanoma cells.
    Stewart AL; Mhashilkar AM; Yang XH; Ekmekcioglu S; Saito Y; Sieger K; Schrock R; Onishi E; Swanson X; Mumm JB; Zumstein L; Watson GJ; Snary D; Roth JA; Grimm EA; Ramesh R; Chada S
    Mol Med; 2002 Aug; 8(8):451-61. PubMed ID: 12435856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PPARδ deficiency disrupts hypoxia-mediated tumorigenic potential of colon cancer cells.
    Jeong E; Koo JE; Yeon SH; Kwak MK; Hwang DH; Lee JY
    Mol Carcinog; 2014 Nov; 53(11):926-37. PubMed ID: 24610641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dysregulation of PTEN in cardiopulmonary vascular remodeling induced by pulmonary hypertension.
    Ravi Y; Selvendiran K; Meduru S; Citro L; Naidu S; Khan M; Rivera BK; Sai-Sudhakar CB; Kuppusamy P
    Cell Biochem Biophys; 2013 Nov; 67(2):363-72. PubMed ID: 22205501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic Reprogramming in Tumor Endothelial Cells.
    García-Caballero M; Sokol L; Cuypers A; Carmeliet P
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Melanoma cell-secreted exosomal miR-155-5p induce proangiogenic switch of cancer-associated fibroblasts via SOCS1/JAK2/STAT3 signaling pathway.
    Zhou X; Yan T; Huang C; Xu Z; Wang L; Jiang E; Wang H; Chen Y; Liu K; Shao Z; Shang Z
    J Exp Clin Cancer Res; 2018 Oct; 37(1):242. PubMed ID: 30285793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endothelial precursor cell-based therapy to target the pathologic angiogenesis and compensate tumor hypoxia.
    Collet G; Szade K; Nowak W; Klimkiewicz K; El Hafny-Rahbi B; Szczepanek K; Sugiyama D; Weglarczyk K; Foucault-Collet A; Guichard A; Mazan A; Nadim M; Fasani F; Lamerant-Fayel N; Grillon C; Petoud S; Beloeil JC; Jozkowicz A; Dulak J; Kieda C
    Cancer Lett; 2016 Jan; 370(2):345-57. PubMed ID: 26577811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topical MTII Therapy Suppresses Melanoma Through PTEN Upregulation and Cyclooxygenase II Inhibition.
    Wu JC; Tsai HE; Hsiao YH; Wu JS; Wu CS; Tai MH
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31968661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a 3D angiogenesis model to study tumour - endothelial cell interactions and the effects of anti-angiogenic drugs.
    Amann A; Zwierzina M; Koeck S; Gamerith G; Pechriggl E; Huber JM; Lorenz E; Kelm JM; Hilbe W; Zwierzina H; Kern J
    Sci Rep; 2017 Jun; 7(1):2963. PubMed ID: 28592821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Exogenous PTEN enhances apoptosis in pancreas cancer cell line ASPC-1 induced by hypoxia].
    Li JJ; Li HY; Chen YZ; Li G; Xin Y
    Zhonghua Zhong Liu Za Zhi; 2006 May; 28(5):345-8. PubMed ID: 17044997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 3D culture broadly regulates tumor cell hypoxia response and angiogenesis via pro-inflammatory pathways.
    DelNero P; Lane M; Verbridge SS; Kwee B; Kermani P; Hempstead B; Stroock A; Fischbach C
    Biomaterials; 2015 Jul; 55():110-8. PubMed ID: 25934456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Engineering a Vascularized Hypoxic Tumor Model for Therapeutic Assessment.
    Ando Y; Oh JM; Zhao W; Tran M; Shen K
    Cells; 2021 Aug; 10(9):. PubMed ID: 34571851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. KLF5 inhibits angiogenesis in PTEN-deficient prostate cancer by attenuating AKT activation and subsequent HIF1α accumulation.
    Ci X; Xing C; Zhang B; Zhang Z; Ni JJ; Zhou W; Dong JT
    Mol Cancer; 2015 Apr; 14():91. PubMed ID: 25896712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.